C-reactive protein and copeptin: Prognostic predictors in chronic obstructive pulmonary disease exacerbations

Andreea L. Antonescu-Turcu, Rade Tomic

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Purpose of review Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a natural event in the course of COPD and remains a major cause of morbidity and mortality associated with this disease. Clinical criteria that define an acute exacerbation are subjective and open for debate. Identifying biomarkers that would be easily measured and followed in patients with acute exacerbation of COPD seems to be highly attractive. The aim of this review is to assess the role of biomarkers, C-reactive protein (CRP) and copeptin, as prognostic predictors in COPD exacerbations. Recent findings Many pulmonary biomarkers have been extensively studied in the recent years. CRP and copeptin have gained particular interest. Recent data suggest that CRP is elevated during an acute exacerbation of COPD but CRP alone is neither sensitive nor specific in predicting clinical severity or outcome. Copeptin increases during acute exacerbation of COPD and may correlate with disease severity. Summary Further studies are needed to determine the role of CRP and copeptin as biomarkers that aid in diagnosis and clinical outcome in acute exacerbation of COPD.

Original languageEnglish (US)
Pages (from-to)120-125
Number of pages6
JournalCurrent Opinion in Pulmonary Medicine
Volume15
Issue number2
DOIs
StatePublished - Mar 1 2009

Fingerprint

C-Reactive Protein
Chronic Obstructive Pulmonary Disease
Disease Progression
Biomarkers
copeptins
Morbidity
Lung
Mortality

Keywords

  • Acute exacerbation of chronic obstructive pulmonary disease
  • C-reactive protein
  • Copeptin
  • Systemic inflammation

Cite this

C-reactive protein and copeptin : Prognostic predictors in chronic obstructive pulmonary disease exacerbations. / Antonescu-Turcu, Andreea L.; Tomic, Rade.

In: Current Opinion in Pulmonary Medicine, Vol. 15, No. 2, 01.03.2009, p. 120-125.

Research output: Contribution to journalReview article

@article{887d01c24e0042428a88d4c3b161fb19,
title = "C-reactive protein and copeptin: Prognostic predictors in chronic obstructive pulmonary disease exacerbations",
abstract = "Purpose of review Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a natural event in the course of COPD and remains a major cause of morbidity and mortality associated with this disease. Clinical criteria that define an acute exacerbation are subjective and open for debate. Identifying biomarkers that would be easily measured and followed in patients with acute exacerbation of COPD seems to be highly attractive. The aim of this review is to assess the role of biomarkers, C-reactive protein (CRP) and copeptin, as prognostic predictors in COPD exacerbations. Recent findings Many pulmonary biomarkers have been extensively studied in the recent years. CRP and copeptin have gained particular interest. Recent data suggest that CRP is elevated during an acute exacerbation of COPD but CRP alone is neither sensitive nor specific in predicting clinical severity or outcome. Copeptin increases during acute exacerbation of COPD and may correlate with disease severity. Summary Further studies are needed to determine the role of CRP and copeptin as biomarkers that aid in diagnosis and clinical outcome in acute exacerbation of COPD.",
keywords = "Acute exacerbation of chronic obstructive pulmonary disease, C-reactive protein, Copeptin, Systemic inflammation",
author = "Antonescu-Turcu, {Andreea L.} and Rade Tomic",
year = "2009",
month = "3",
day = "1",
doi = "10.1097/MCP.0b013e3283218603",
language = "English (US)",
volume = "15",
pages = "120--125",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - C-reactive protein and copeptin

T2 - Prognostic predictors in chronic obstructive pulmonary disease exacerbations

AU - Antonescu-Turcu, Andreea L.

AU - Tomic, Rade

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Purpose of review Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a natural event in the course of COPD and remains a major cause of morbidity and mortality associated with this disease. Clinical criteria that define an acute exacerbation are subjective and open for debate. Identifying biomarkers that would be easily measured and followed in patients with acute exacerbation of COPD seems to be highly attractive. The aim of this review is to assess the role of biomarkers, C-reactive protein (CRP) and copeptin, as prognostic predictors in COPD exacerbations. Recent findings Many pulmonary biomarkers have been extensively studied in the recent years. CRP and copeptin have gained particular interest. Recent data suggest that CRP is elevated during an acute exacerbation of COPD but CRP alone is neither sensitive nor specific in predicting clinical severity or outcome. Copeptin increases during acute exacerbation of COPD and may correlate with disease severity. Summary Further studies are needed to determine the role of CRP and copeptin as biomarkers that aid in diagnosis and clinical outcome in acute exacerbation of COPD.

AB - Purpose of review Acute exacerbation of chronic obstructive pulmonary disease (COPD) is a natural event in the course of COPD and remains a major cause of morbidity and mortality associated with this disease. Clinical criteria that define an acute exacerbation are subjective and open for debate. Identifying biomarkers that would be easily measured and followed in patients with acute exacerbation of COPD seems to be highly attractive. The aim of this review is to assess the role of biomarkers, C-reactive protein (CRP) and copeptin, as prognostic predictors in COPD exacerbations. Recent findings Many pulmonary biomarkers have been extensively studied in the recent years. CRP and copeptin have gained particular interest. Recent data suggest that CRP is elevated during an acute exacerbation of COPD but CRP alone is neither sensitive nor specific in predicting clinical severity or outcome. Copeptin increases during acute exacerbation of COPD and may correlate with disease severity. Summary Further studies are needed to determine the role of CRP and copeptin as biomarkers that aid in diagnosis and clinical outcome in acute exacerbation of COPD.

KW - Acute exacerbation of chronic obstructive pulmonary disease

KW - C-reactive protein

KW - Copeptin

KW - Systemic inflammation

UR - http://www.scopus.com/inward/record.url?scp=62349134599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62349134599&partnerID=8YFLogxK

U2 - 10.1097/MCP.0b013e3283218603

DO - 10.1097/MCP.0b013e3283218603

M3 - Review article

C2 - 19532026

AN - SCOPUS:62349134599

VL - 15

SP - 120

EP - 125

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 2

ER -